NO20055450L - Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon - Google Patents

Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon

Info

Publication number
NO20055450L
NO20055450L NO20055450A NO20055450A NO20055450L NO 20055450 L NO20055450 L NO 20055450L NO 20055450 A NO20055450 A NO 20055450A NO 20055450 A NO20055450 A NO 20055450A NO 20055450 L NO20055450 L NO 20055450L
Authority
NO
Norway
Prior art keywords
treatment
depression
combination
antidepressant compound
modafinil
Prior art date
Application number
NO20055450A
Other languages
English (en)
Other versions
NO334448B1 (no
NO20055450D0 (no
Inventor
Rodney J Hughes
Howard Hassmann
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20055450D0 publication Critical patent/NO20055450D0/no
Publication of NO20055450L publication Critical patent/NO20055450L/no
Publication of NO334448B1 publication Critical patent/NO334448B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Preparater og metoder for behandling av depressive lidelser gjennom administrering av modafinil med antidepressiva.
NO20055450A 2003-05-13 2005-11-17 Farmasøytisk preparat som omfatter modafinil og et antidepressivt middel NO334448B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46994303P 2003-05-13 2003-05-13
US10/844,187 US20040229942A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations
PCT/US2004/015194 WO2004100937A1 (en) 2003-05-13 2004-05-13 Combination of the analeptic modafinil and an antidepressant for the treatment of depression

Publications (3)

Publication Number Publication Date
NO20055450D0 NO20055450D0 (no) 2005-11-17
NO20055450L true NO20055450L (no) 2006-02-01
NO334448B1 NO334448B1 (no) 2014-03-03

Family

ID=33423928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055450A NO334448B1 (no) 2003-05-13 2005-11-17 Farmasøytisk preparat som omfatter modafinil og et antidepressivt middel

Country Status (25)

Country Link
US (1) US20040229942A1 (no)
EP (1) EP1628652B1 (no)
JP (1) JP5553955B2 (no)
KR (1) KR20060019537A (no)
AR (1) AR045423A1 (no)
AU (1) AU2004238379B2 (no)
BR (1) BRPI0411174A (no)
CA (1) CA2525524C (no)
CY (1) CY1113154T1 (no)
DK (1) DK1628652T3 (no)
EA (1) EA012173B1 (no)
ES (1) ES2390225T3 (no)
HK (1) HK1087645A1 (no)
HR (1) HRP20120713T1 (no)
IS (1) IS8097A (no)
MX (1) MXPA05012144A (no)
MY (1) MY140179A (no)
NO (1) NO334448B1 (no)
NZ (1) NZ544135A (no)
PL (1) PL1628652T3 (no)
PT (1) PT1628652E (no)
SI (1) SI1628652T1 (no)
TW (1) TWI409061B (no)
UA (1) UA89753C2 (no)
WO (1) WO2004100937A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283008A1 (en) * 2000-07-27 2002-02-13 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
CA2614777C (en) * 2005-07-21 2012-04-17 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
CA2660565C (en) * 2006-08-14 2012-10-09 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
JP6614014B2 (ja) * 2016-04-26 2019-12-04 信越化学工業株式会社 含窒素オルガノキシシラン化合物およびその製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (no) * 1993-06-22 1995-09-08 Lafon Labor
US5933841A (en) * 1996-05-17 1999-08-03 Ameritech Corporation Structured document browser
US5890172A (en) * 1996-10-08 1999-03-30 Tenretni Dynamics, Inc. Method and apparatus for retrieving data from a network using location identifiers
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6359635B1 (en) * 1999-02-03 2002-03-19 Cary D. Perttunen Methods, articles and apparatus for visibly representing information and for providing an input interface
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
WO2001013921A1 (en) * 1999-08-23 2001-03-01 Ockert David M Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
JP2007505156A (ja) 2007-03-08
CA2525524C (en) 2012-09-25
KR20060019537A (ko) 2006-03-03
WO2004100937B1 (en) 2006-12-21
PL1628652T3 (pl) 2012-12-31
PT1628652E (pt) 2012-09-28
MXPA05012144A (es) 2006-02-08
CA2525524A1 (en) 2004-11-25
IS8097A (is) 2005-10-27
WO2004100937A1 (en) 2004-11-25
US20040229942A1 (en) 2004-11-18
NO334448B1 (no) 2014-03-03
BRPI0411174A (pt) 2006-07-18
TWI409061B (zh) 2013-09-21
JP5553955B2 (ja) 2014-07-23
NZ544135A (en) 2008-09-26
HRP20120713T1 (hr) 2012-09-30
CY1113154T1 (el) 2016-04-13
TW200500063A (en) 2005-01-01
MY140179A (en) 2009-11-30
NO20055450D0 (no) 2005-11-17
EA012173B1 (ru) 2009-08-28
AR045423A1 (es) 2005-10-26
EA200501802A1 (ru) 2006-06-30
UA89753C2 (ru) 2010-03-10
AU2004238379A1 (en) 2004-11-25
EP1628652A1 (en) 2006-03-01
DK1628652T3 (da) 2012-10-08
AU2004238379B2 (en) 2009-08-20
EP1628652B1 (en) 2012-07-11
SI1628652T1 (sl) 2012-11-30
HK1087645A1 (en) 2006-10-20
ES2390225T3 (es) 2012-11-07

Similar Documents

Publication Publication Date Title
NO20055450L (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
NO20055448L (no) Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon
NO20034056D0 (no) Proliferative sykdommer
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200700333A1 (ru) Терапевтические применения ингибиторов rtp801
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
DK1503788T3 (da) Behandling af alpha-galactosidase A-deficiens
TW200509896A (en) Analeptic and drug combinations
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
TW200509895A (en) Analeptic and antidepressant combinations
ATE399532T1 (de) Medizinische seife
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
TW200509894A (en) Analeptic and antidepressant combinations
ATE383874T1 (de) Perylenequinonen zur anwendung als sonosensitizer
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
DE60322577D1 (de) Tablette enthaltend efletirizin und pseudoephedrin
ZA200510097B (en) Combination of the analeptic modafinil and an antidepressant for the treatment of depression
AR044360A1 (es) Composiciones farmaceuticas que comprenden un analeptico y otros farmacos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees